Metraipolis › archive › dc_f5f6f72bcd9e
Complete response following trastuzumab-deruxtecan in a man with HER2-overexpressing metastatic, poorly differentiated scrotal carcinoma — Europe PMC PMID:41330720
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41330720
- DOI
- 10.1093/oncolo/oyaf398
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T01:38:57.248Z
- SHA-256 of the archived text
aeb7cacb74117904917ec23db2d2f2fcc0d49019125fd7a8107d63998e08a9b9- Stable URL of this page
https://metraipolis.com/documento/dc_f5f6f72bcd9e
How to cite
Complete response following trastuzumab-deruxtecan in a man with HER2-overexpressing metastatic, poorly differentiated scrotal carcinoma — Europe PMC PMID:41330720 — Europe PMC (en), https://europepmc.org/article/MED/41330720 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f5f6f72bcd9e (Metraipolis archive dc_f5f6f72bcd9e, sha256 aeb7cacb74117904917ec23db2d2f2fcc0d49019125fd7a8107d63998e08a9b9)
BibTeX
@misc{dcf5f6f72bcd9e,
title = {Complete response following trastuzumab-deruxtecan in a man with HER2-overexpressing metastatic, poorly differentiated scrotal carcinoma — Europe PMC PMID:41330720},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41330720},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f5f6f72bcd9e; sha256 aeb7cacb74117904917ec23db2d2f2fcc0d49019125fd7a8107d63998e08a9b9},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41330720. Agents can read the archived copy with the MCP tool read_document.